selected publications
-
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation.
Bone marrow transplantation.
2020
Letter
GET IT
Times cited: 4 -
Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
Current opinion in hematology.
2020
Information Resource
GET IT
Times cited: 2 -
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2020
Academic Article
GET IT
Times cited: 41 -
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.
The Journal of clinical investigation.
2020
Academic Article
GET IT
Times cited: 152 - Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34+ selected graft. Bone marrow transplantation. 2019 Letter GET IT
-
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies.
Bone marrow transplantation.
2019
Academic Article
GET IT
Times cited: 37 -
Second allogeneic hematopoietic cell transplantation for relapse after first allografts.
Leukemia & lymphoma.
2019
Academic Article
GET IT
Times cited: 12 -
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2019
Academic Article
GET IT
Times cited: 7 -
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.
Science translational medicine.
2018
Academic Article
GET IT
Times cited: 235 -
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2018
Academic Article
GET IT
Times cited: 12 -
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 13 -
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 10 -
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 9 -
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2017
Academic Article
GET IT
Times cited: 230 -
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
Science translational medicine.
2016
Academic Article
GET IT
Times cited: 377 -
Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell Transplantation.
The oncologist.
2015
Academic Article
GET IT
Times cited: 36 -
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.
Nature genetics.
2015
Academic Article
GET IT
Times cited: 283 -
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.
Blood.
2014
Information Resource
GET IT
Times cited: 372 -
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation.
Leukemia.
2014
Academic Article
GET IT
Times cited: 176 -
Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2014
Academic Article
GET IT
Times cited: 42 -
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.
Blood.
2013
Academic Article
GET IT
Times cited: 290 -
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2013
Academic Article
GET IT
Times cited: 177 -
Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2013
Academic Article
GET IT
Times cited: 24 -
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.
Blood.
2012
Academic Article
GET IT
Times cited: 137 -
Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.
Cancer.
2011
Academic Article
GET IT
Times cited: 24 -
Identifying older patients with acute myeloid leukemia who may be candidates for reduced-intensity hematopoietic cell transplantation.
Journal of the National Comprehensive Cancer Network : JNCCN.
2011
Academic Article
GET IT
Times cited: 4 -
Allogeneic hematopoietic cell transplantation: the state of the art.
Expert review of hematology.
2010
Information Resource
GET IT
Times cited: 138 -
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2010
Academic Article
GET IT
Times cited: 184 -
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2009
Academic Article
GET IT
Times cited: 25 -
Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors.
Journal of the National Cancer Institute.
2006
Academic Article
GET IT
Times cited: 79